Related Experiment Video
Updated: Jun 19, 2026

Isolation of Human Atrial Myocytes for Simultaneous Measurements of Ca2+ Transients and Membrane Currents
Published on: July 3, 2013
Differential association of phosphodiesterase 4D isoforms with beta2-adrenoceptor in cardiac myocytes
Vania De Arcangelis1, Ruijie Liu, Dagoberto Soto
1Department of Molecular and Integrative Physiology, University of Illinois at Urbana-Champaign, Urbana, Illinois 61801, USA.
Abstract:
cAMP and protein kinase A (PKA) activation represents a key signaling mechanism upon beta-adrenergic stimulation under stress. Both beta(1)- and beta(2)-adrenoreceptor (ARs) subtypes induce cAMP accumulation, yet play distinct roles in cardiac contraction and myocyte apoptosis. Differences in controlling cAMP/PKA activities through the assembly of complexes between the receptors and cAMP-specific phosphodiesterases contribute to the distinct biological outcomes. Here, we demonstrate that beta(2)ARs form signaling complexes with a set of PDE4D isoforms expressed in cardiac myocytes. PDE4D9 and PDE4D8 bind to the beta(2)AR at resting conditions; however, agonist stimulation induces dissociation of PDE4D9 from the receptor but recruitment of PDE4D8 to the receptor. Agonist stimulation also induces recruitment of PDE4D5 to the beta(2)AR. Moreover, the receptor-associated PDE4D isoforms play distinct roles in controlling cAMP activities and regulating the PKA phosphorylation of the receptor and myocyte contraction rate responses. Knockdown of PDE4D9 with short hairpin RNA enhances the beta(2)AR-induced cAMP signaling, whereas knockdown of PDE4D8 only slightly prolongs the receptor-induced cAMP signaling in myocytes. Inhibition of PDE4D9 and PDE4D5 enhances the base-line levels of contraction rates, whereas inhibition of PDE4D9 and PDE4D8 enhances the maximal contraction rate increases upon activation of beta(2)AR. Our data underscore the complex regulation of intracellular cAMP by beta(2)AR-associated phosphodiesterase enzymes to enforce the specificity of the receptor signaling for physiological responses.
Insights
Beta-2 adrenergic receptors (β2ARs) interact with specific PDE4D phosphodiesterases in heart cells. These interactions precisely control cyclic AMP (cAMP) signaling, influencing heart contraction and cell survival under stress.
Area of Science:
- Cardiology
- Molecular Biology
- Pharmacology
Background:
- Beta-adrenergic stimulation activates cyclic AMP (cAMP) and protein kinase A (PKA), crucial for cardiac function during stress.
- Both beta(1)- and beta(2)-adrenergic receptors (ARs) mediate cAMP accumulation but have distinct roles in cardiac contraction and apoptosis.
- The assembly of receptor-phosphodiesterase complexes dictates specific cAMP/PKA activities and downstream effects.
Purpose of the Study:
- To investigate the interaction between beta(2)ARs and specific phosphodiesterase 4D (PDE4D) isoforms in cardiac myocytes.
- To elucidate the roles of distinct PDE4D isoforms in regulating beta(2)AR-mediated cAMP signaling and cardiac function.
Main Methods:
- Studied the formation of beta(2)AR-PDE4D signaling complexes in cardiac myocytes.
- Utilized short hairpin RNA (shRNA) to knock down PDE4D isoforms.
- Assessed the impact of PDE4D isoform modulation on cAMP signaling and myocyte contraction rates.
Main Results:
- Beta(2)ARs form complexes with PDE4D9 and PDE4D8 at rest; agonist stimulation alters these interactions, recruiting PDE4D5.
- Knockdown of PDE4D9 potentiates beta(2)AR-induced cAMP signaling, while PDE4D8 knockdown has a minor effect.
- Inhibition of PDE4D9/PDE4D5 increases baseline contraction, whereas PDE4D9/PDE4D8 inhibition enhances maximal contraction upon beta(2)AR activation.
Conclusions:
- Specific PDE4D isoforms associated with beta(2)ARs differentially regulate cAMP signaling in cardiac myocytes.
- These interactions are critical for the precise control of beta(2)AR-mediated physiological responses, including myocyte contraction.
- Understanding these complexes offers insights into targeted therapeutic strategies for cardiovascular conditions.
Related Concept Videos
Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Adrenergic Receptors: ɑ Subtype
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
Adrenergic Receptors (Adrenoceptors): Classification
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors, which are found on postsynaptic...
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
G-Protein Gated Ion Channels
Sensory organs,...
Sympathetic Signaling
Sympathetic preganglionic fibers release the neurotransmitter acetylcholine (ACh) onto the ganglionic neurons in the...

